BOXER CAPITAL
Boxer Capital caters to public companies based in the biotechnology industry.
BOXER CAPITAL
Industry:
Biotechnology Venture Capital
Founded:
2005-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-09-07 | SpringWorks Therapeutics | Boxer Capital investment in Post-IPO Equity - SpringWorks Therapeutics | 225 M USD |
2022-07-13 | Gossamer Bio | Boxer Capital investment in Post-IPO Equity - Gossamer Bio | 120 M USD |
2022-03-31 | Incyclix Bio | Boxer Capital investment in Series B - Incyclix Bio | 30 M USD |
2022-03-16 | 2seventy bio | Boxer Capital investment in Post-IPO Equity - 2seventy bio | 170 M USD |
2022-02-09 | Seismic Therapeutic | Boxer Capital investment in Series A - Seismic Therapeutic | 101 M USD |
2022-01-19 | Alterome Therapeutics | Boxer Capital investment in Series A - Alterome Therapeutics | 64 M USD |
2022-01-19 | Ceptur Therapeutics | Boxer Capital investment in Series A - Ceptur Therapeutics | 75 M USD |
2022-01-19 | Enliven Therapeutics | Boxer Capital investment in Series B - Enliven Therapeutics | 85 M USD |
2022-01-16 | Third Harmonic Bio | Boxer Capital investment in Series B - Third Harmonic Bio | 105 M USD |
2021-12-17 | EQRx | Boxer Capital investment in Post-IPO Equity - EQRx | 1.2 B USD |
More informations about "Boxer Capital"
Boxer Capital - Crunchbase Investor Profile
Boxer Capital caters to public companies based in the biotechnology industry. Windermere, Florida, United States; 11-50; Venture Capital Early Stage Venture, Late Stage Venture, Post-Ipo, Venture ... Sub-Organization of . Tavistock Life โฆSee details»
Private Investment Firm | Boxer Capital
Boxer Capital Management is a biotechnology investment firm dedicated to fundamental, research-based investing in specialized and precision medicine. For nearly two decades, the senior investment team has been located in the life โฆSee details»
Boxer Capital - The Org
Boxer Capital, LLC, is a private biotechnology investment fund that invents and invests in biotechnology development across multiple therapeutic indications. Industries. Venture โฆSee details»
Boxer Capital - Investments, Portfolio & Company Exits - Crunchbase
Boxer Capital 's most notable exits include Avidity Biosciences, Spyre Therapeutics, and enGene. Which industries has this organization had the most exits in? Show . Avidity Biosciences โฆSee details»
Boxer Capital 13F annual report (2024) - wallmine
$1.9 trillion Assets Under Management (AUM) As of 8th May 2024, Boxer Capitalโs top holding is 3,421,541 shares of SpringWorks Therapeutics currently worth over $168 billion and making โฆSee details»
Biotech Venture Capital | Highlights | Boxer Capital
Invested in by Boxer Capital 1 since 2014; 51 liquidity events (IPO, public access or acquisition) 14 private investments led or co-led by Boxer Capital 1; 1. Reflects investments that were made by Boxer Capital, LLC prior to the corporate โฆSee details»
Boxer Capital - Massinvestor Venture Capital and Private Equity โฆ
Boxer Capital, LLC, is a private investment fund based in San Diego, California that invents and invests in biotechnology drug development across multiple therapeutic indications. Founded โฆSee details»
Boxer Capital Management | LinkedIn
Boxer Capital Management, LLC is a full life cycle investment firm committed to fundamental, research-based investing in specialized and precision medicine companies across private and โฆSee details»
Boxer Capital Investor Information - Funding, Portfolio Companies, โฆ
Boxer Capital, based in San Diego, specializes in investing in biotech and health tech startups at the Series C stage. Founded in 2005, it supports the development of new therapeutics, โฆSee details»
List of top Boxer Capital Portfolio Companies - Crunchbase
Boxer Capital caters to public companies based in the biotechnology industry. This list of organizations invested in by Boxer Capital provides data on their funding history, investment โฆSee details»
Boxer Capital investment portfolio - PitchBook
Boxer Capital's latest investment was on 29-Oct-2024 in Crescent Biopharma, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover how โฆSee details»
Boxer Capital - Private Equity List
Boxer Capital, LLC, is a private biotechnology investment fund based in San Diego, California that invents and invests in new therapeutics across multiple indications in order to create value โฆSee details»
Aaron Davis - Co-Founder, Chief Executive Officer at Boxer Capital ...
Aaron Davis is Co-Founder and Chief Executive Officer of Boxer Capital, LLC. In 2005, after joining Tavistock Group as Portfolio Manager, Mr. Davis scaled Tavistock Groupโs public โฆSee details»
Boxer Capital Fund: Performance - PitchBook
Boxer Capital Fund General Information Description. Boxer Capital Fund is a venture capital fund managed by Boxer Capital. The fund is located in San Diego, California. The fund invests in โฆSee details»
BOXER CAPITAL, LLC Top 13F Holdings - WhaleWisdom.com
Boxer Capital is a hedge fund with 1 clients and discretionary assets under management (AUM) of $2,543,913,691 (Form ADV from 2024-11-01). Their last reported 13F filing for Q3 2024 โฆSee details»
Bruce Turner - Executive in Residence at Boxer Capital - The Org
Bruce Turner, M.D., Ph.D., joined Boxer Capital, LLC in 2017. Prior to joining Boxer, Dr. Turner was employed at Hoffman-La Roche for five years, where his most recent role was working โฆSee details»
Aaron Davis - Co-Founder and CEO @ Boxer Capital - Crunchbase
Primary Organization . Boxer Capital . Location San Diego, California, United States; Regions Greater San Diego Area, West ... Aaron Davis is the Co-Founder and CEO at Boxer Capital. โฆSee details»
Norman Zhou, Ph.D. | Vivace
Norman Zhou, Ph.D., joined Boxer Capital Management, LLC in 2016. As Managing Director, Dr. Zhou is responsible for conducting due diligence of public and private investments in โฆSee details»
BOXER CAPITAL, LLC SC 13D/A Filing Concerning ODTCD on 2021 โฆ
Nov 24, 2021 This Amendment No. 4 (โAmendment No. 4โ) amends and supplements the statement on Schedule 13D filed on December 8, 2017 (the โOriginal Filingโ) by Boxer Capital, โฆSee details»
Boxer debuts on JSE, outshines parent Pick n Pay in value
2 days ago Pick n Pay acquired Boxer in 2002, under the leadership of Sean Summers, during his first stint as chief executive. At the time, it had 35 stores and annual sales of R800 million.See details»